Processa Pharmaceuticals, Inc. (PCSA)
| Previous Close | 7.69 |
| Open | 7.75 |
| Bid | 7.80 x 800 |
| Ask | 7.91 x 1300 |
| Day's Range | 7.65 - 7.91 |
| 52 Week Range | 4.05 - 14.24 |
| Volume | 27,909 |
| Avg. Volume | 99,779 |
| Market Cap | 121.689M |
| Beta (5Y Monthly) | -0.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.08 |
| Earnings Date | Mar. 25, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.00 |
- GlobeNewswire
Processa Pharmaceuticals Cleared by FDA to Proceed with Phase 2a Trial for the Treatment of Gastroparesis
HANOVER, MD, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, announced today that they have been cleared by the U.S. Food and Drug Administration (FDA) to proceed with a Phase 2a clinical trial of PCS12852 in patients with moderate to severe gastroparesis, an unmet medical need cond
- GlobeNewswire
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences - Update
HANOVER, MD, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, announced today that management will participate in upcoming investor conferences: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Date and Time: 9/22/2021 9:05 AM (ET)Webcast: https://wsw.com/webcast/oppenheim
- GlobeNewswire
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
HANOVER, MD, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, announced today that management will participate in upcoming investor conferences: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Date and Time: 9/22/2021 9:05 AM (ET)Webcast: https://wsw.com/webcast/oppenheim
